Search results
Results from the WOW.Com Content Network
The Self-administered Gerocognitive Examination is a brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia, created by Douglas Scharre, Professor of Clinical Neurology and Psychiatry at Ohio State University Wexner Medical Center in Columbus, Ohio. A digital version exists. [1]
In community samples, cutoff scores for likely dementia have ranged from 3.3 and above to 3.6 and above, while in patient samples the cutoff scores have ranged from 3.4 and above to 4.0 and above. [3] To improve the detection of dementia, the IQCODE can be used in combination with the Mini-Mental State Examination.
Caregiver burden refers to the physical, emotional, social, and financial challenges experienced by individuals who provide care for someone with Alzheimer's disease or other forms of dementia. Caregivers often experience a range of emotions, including stress, anxiety, depression , guilt, and grief.
Stage 6 dementia marks a need for caregiver help to perform basic daily activities, such as eating, using the toilet, and other self-care. Seniors experiencing this stage of moderately severe ...
A recently conducted study in Australia [8] found that the GPCOG in comparison to the MMSE and Rowland Universal Dementia Assessment Scale (RUDAS) [9] was best to rule out dementia in a multicultural cohort of 151 community-dwelling persons. [8] Its sensitivity was higher (98.1) as compared to MMSE and RUDAS (84.3 and 87.7, respectively).
The Bristol Activities of Daily Living Scale (BADLS) is a 20-item questionnaire designed to measure the ability of someone with dementia to carry out daily activities such as dressing, preparing food and using transport. [1] [2] [3]
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1 ] and is considered to be the “gold standard” for assessing antidementia treatments.
It is scored out of 100, with a higher score denoting better cognitive function. At the recommended cut-off scores of 88 and 83, the ACE was reported to have good sensitivity and specificity for identifying different forms of dementia and other impairments of memory and judgement (0.93 and 0.71; 0.82 and 0.96, respectively). [5]